Disease Modeling Using 3D Organoids Derived from Human Induced Pluripotent Stem Cells

Area of Science:

• Stem Cell Biology
• Developmental Biology
• Biotechnology

Background:

• Organoids are 3D structures mimicking embryonic and tissue development in vitro.
• Human induced pluripotent stem cell (hiPSC)-derived organoids are increasingly studied for their resemblance to in vivo tissues.
• Organoid models surpass traditional 2D cultures in recapitulating tissue architecture and function.

Purpose of the Study:

• To review recent advancements in 3D organoid technology for disease modeling.
• To highlight organoid applications in hereditary diseases, cancer, and host-microbe interactions.
• To discuss the utility of organoids in personalized medicine and pharmaceutical screening.

Main Methods:

• Utilizing directed multi-lineage differentiation and morphogenetic processes.
• Employing hiPSC technology to generate organoid cultures.
• Applying organoids for high-throughput pharmaceutical screening and biomarker discovery.

Main Results:

• Organoids accurately mirror in vivo tissue functionality, architecture, and geometric features.
• Organoid cultures facilitate the discovery of diagnostic biomarkers for early disease detection.
• Organoid models enable better recapitulation of drug responses in vitro.

Conclusions:

• hiPSC-derived organoids provide a powerful in vitro model for studying complex human diseases.
• Organoid technology holds significant promise for translational medicine and personalized healthcare.
• The recapitulation of disease processes and drug responses in organoids aids in understanding disease mechanisms.